Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch
06. November 2024 15:14 ET
|
Avricore Health Inc.
Avricore earned 8th spot in Deloitte Canada’s 2024 Technology Fast 50™ Companies-to-Watch list, reflecting its significant growth.
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion
08. August 2023 11:54 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller...
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom
03. August 2023 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased that HealthTab, the Company’s leading...
HealthTab™ to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights
19. Juli 2023 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia...
Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
21. Juni 2023 18:38 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and...
Prati-Donaduzzi Secures the Largest Global Pharma Supply Agreement for Natural Cannabinoids with API Manufacturer Brains Bioceutical
04. April 2023 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), the largest natural cannabinoid active pharmaceutical ingredient (“API”)...
Avricore Health Reports Third-Quarter 2022 Results
29. November 2022 11:08 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth,...
CRISPR Gene Editing Market Size is projected to reach USD 14.80 Billion by 2030, growing at a CAGR of 29.80%: Straits Research
01. August 2022 12:40 ET
|
Straits Research
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Gene Editing, also called genome editing, modifies an organism's DNA. This method replaces, adds, or removes genetic material from...
Shital Mars CEO of Progressive Care Inc. Garners Coverage in Authority Magazine as a Hero of the Opioid Crisis
10. Januar 2019 08:00 ET
|
Progressive Care, Inc.
MIAMI, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in...
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
14. November 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s...